| Business Name: |
Nascimento Tome MD |
| Contact Person: |
Tome Nascimento |
| Address: |
318 Chris Gaupp Drive, Absecon, New Jersey 08205 |
| Phone Number: |
(609) 404-9900 |
| Website Address: |
mainlandheart.com |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Kosmorsky Paul M DO - Absecon, NJ 08205
Wisniewski Mary L MD - Absecon, NJ 08205
Patel Mayuri H MD - Absecon, NJ 08205
Adams Andrea G MD - Absecon, NJ 08205
Vankawala Viren R MD - Absecon, NJ 08205
Wjasow Christina MD - Absecon, NJ 08205
Bell Theresa A MD - Absecon, NJ 08205
Dasondi Vivek MD - Absecon, NJ 08205
Paparone Basil MD - Absecon, NJ 08205
Huang Jun MD - Absecon, NJ 08205
Durojaye Abike O MD - Absecon, NJ 08205
Grayson Stephanie MD - Absecon, NJ 08205
Geraci Brian MD - Absecon, NJ 08205
Trivedi Niranjan MD - Absecon, NJ 08205
Langel Dely MD - Absecon, NJ 08205
Coville Frederick MD - Absecon, NJ 08205
Center For Venous And Lymphatic Disorders - Absecon, NJ 08205
Friedman Alan S MD - Absecon, NJ 08205
Hee Duk MD - Absecon, NJ 08205
Eliana Selina MD - Absecon, NJ 08205
|
The company Nascimento Tome MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Nascimento Tome MD, and the business now earns $500.000 to $999.999 per annum.
Nascimento Tome MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Nascimento Tome MD, please call Tome Nascimento with the phone number (609) 404-9900 or visit its single location at 318 Chris Gaupp Drive in Absecon, New Jersey 08205.
The location of the single location can also be found using the coordinates 39.47313,-74.54243.
Read more details about this business on the webpage mainlandheart.com or follow the company’s social media accounts, on Twitter and on Facebook.